Trials / Recruiting
RecruitingNCT06539013
Efficacy of Remifentanil in Preventing Emergence Agitation
Efficacy of Remifentanil in Preventing Emergence Agitation in Patients Undergoing Nasal Surgery Under Desflurane Anesthesia: A Prospective Double-blind Randomized Controlled Trial.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 99 (estimated)
- Sponsor
- Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The primary aim of the study was to test the hypothesis that remifentanil administered for analgesia prevents emergence agitation more effectively than fentanyl and N2O in patients undergoing rhinoplasty who received desflurane as an inhaled anesthetic agent. The secondary aim of the study was to compare the demographic data, intraoperative and postoperative hemodynamic data, surgical time and modified Aldrete score of patients who received different intraoperative analgesia methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil | remifentanil infusion |
| DRUG | N2O | Use of N2O for analgesia |
| DRUG | Fentanyl | Use of Fentanylfor analgesia |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2024-09-30
- Completion
- 2024-10-01
- First posted
- 2024-08-06
- Last updated
- 2024-08-06
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06539013. Inclusion in this directory is not an endorsement.